Prospective Double Blind Evaluation of Levetiracetam (Keppra) for the Treatment of Cervical Dystonia.

Trial Profile

Prospective Double Blind Evaluation of Levetiracetam (Keppra) for the Treatment of Cervical Dystonia.

Suspended
Phase of Trial: Phase II

Latest Information Update: 14 Oct 2008

At a glance

  • Drugs Levetiracetam (Primary) ; Botulinum toxin A
  • Indications Torticollis
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top